[Federal Register Volume 76, Number 244 (Tuesday, December 20, 2011)]
[Notices]
[Pages 78924-78925]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2011-32495]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[30-Day-12-11DT]


Agency Forms Undergoing Paperwork Reduction Act Review

    The Centers for Disease Control and Prevention (CDC) publishes a 
list of information collection requests under review by the Office of 
Management and Budget (OMB) in compliance with the Paperwork Reduction 
Act (44 U.S.C. chapter 35). To request a copy of these requests, call 
the CDC Reports Clearance Officer at (404) 639-5960 or send an email to 
[email protected]. Send written comments to CDC Desk Officer, Office of 
Management and Budget, Washington, DC 20503 or by fax to (202) 395-
5806. Written comments should be received within 30 days of this 
notice.

Proposed Project

    Monitoring Outcomes of the Enhanced Comprehensive HIV Prevention 
Plan (ECHPP) Project -New- National Center for HIV/AIDS, Viral 
Hepatitis, STD, and TB Prevention (NCHHSTP), Centers for Disease 
Control and Prevention (CDC).

Background and Brief Description

    The scope of the HIV epidemic in the United States is significant, 
particularly in large urban areas where HIV/AIDS cases are 
concentrated. In 2006, approximately 56,000 new HIV infections occurred 
in the U.S., demonstrating the need to expand targeted HIV prevention 
efforts. In 2010, twelve U.S. metropolitan statistical areas (MSAs) 
received funding, through their city and state health departments, to 
conduct the Enhanced Comprehensive HIV Prevention Planning (ECHPP) 
project. These twelve MSAs (Atlanta, GA; Baltimore, MD; Chicago, IL; 
Dallas, TX; District of Columbia; Houston, TX; Los Angeles, CA; Miami, 
FL; New York City, NY; Philadelphia, PA; San Francisco, CA; and San 
Juan, PR) had the highest AIDS prevalence rates in the U.S. at the end 
of 2007, representing 44% of all U.S. AIDS cases. The purpose of ECHPP 
is to enhance existing HIV prevention services in these high prevalence 
areas and provide an optimal mix of evidence-based behavioral, 
biomedical, and structural interventions to have maximum impact on the 
HIV/AIDS epidemic at the community level. ECHPP goals are consistent 
with CDC's Division of HIV/AIDS Prevention Strategic Plan for HIV 
Prevention and with the National HIV/AIDS Strategy: (1) Prevent new HIV 
infections, (2) increase linkage to, and impact of, prevention and care 
services for HIV-positive individuals, and (3) reduce HIV-related 
health disparities.
    To evaluate ECHPP's impact on the HIV/AIDS epidemic at the 
community level, data will be collected through both existing CDC data 
sources and through new data collection activities. Existing CDC data 
sources will include HIV surveillance systems (e.g., National HIV 
Behavioral Surveillance System, Medical Monitoring Project) that 
routinely collect information about behavioral and clinical outcomes 
from at-risk target populations in the 12 MSAs. A new data collection 
activity is proposed through this project to collect information about 
behavioral and clinical outcomes from injection drug users, high-risk 
heterosexuals, and HIV-positive individuals who access medical care in 
six of the 12 ECHPP-funded MSAs. These MSAs are: District of Columbia; 
Houston, TX; Los Angeles, CA; Miami, FL; New York City, NY; and San 
Francisco, CA. The purpose of this new data collection activity is to 
monitor community-level outcomes of ECHPP and supplement HIV 
surveillance data routinely collected in these areas. Outcome data will 
be collected in these MSAs at two time points between 2012 and 2014.
    Two surveys will be used in this project: (1) A community-based 
survey to be administered to injection drug users and high-risk 
heterosexuals, and (2) a clinic-based survey to be administered to HIV-
positive individuals seeking care at clinics that provide HIV-related 
services. Both surveys will collect data on demographics, sexual 
behavior, alcohol and drug use history, HIV testing experiences, 
exposure to HIV prevention messages, and participation in HIV 
prevention activities. The clinic survey will also include questions 
about HIV treatment, treatment adherence, sources of care, and medical 
outcomes. For the community survey, for each of the two data collection 
periods, we intend to recruit and screen 750 injection drug users and 
750 high-risk heterosexuals using venue-based, convenience sampling 
methods. For the clinic survey, we intend to recruit and screen 1400 
HIV-positive individuals seeking HIV care at medical clinics. A total 
of 600 eligible injection drug users (age  18 yrs), 600 
eligible high-risk heterosexuals (age 18 to 60 yrs), and 1200 eligible 
HIV-positive individuals (age  18 yrs) will be surveyed. CDC 
will collaborate with local health department staff and outreach 
workers

[[Page 78925]]

in each MSA to identify venues and clinics appropriate for data 
collection. Surveys will be administered by trained, local 
interviewers. There is no cost to respondents other than their time. 
The total annual burden hours are 1,704.

                                       Estimate of Annualized Burden Table
----------------------------------------------------------------------------------------------------------------
                                                                                                      Average
                                                                     Number of       Number of      burden per
         Data collection form                  Respondent           respondents    responses per   response  (in
                                                                                    respondent        hours)
----------------------------------------------------------------------------------------------------------------
Project orientation...................  Clinic staff............              40               1           30/60
Clinic Staff Script--Provision of       Clinic staff............             600               1            5/60
 Patient Loads.
Clinic Staff Script--Approaching        Clinic staff............           1,100               1            5/60
 Clients.
Clinic Screener.......................  HIV-positive individuals           1,400               1            5/60
                                         screened.
Clinic Survey.........................  Eligible HIV-positive              1,200               1           40/60
                                         individuals.
Community Screener....................  Injection drug users                 750               1            5/60
                                         screened.
Community Survey......................  Eligible injection drug              600               1           25/60
                                         users.
Community Screener....................  High-risk heterosexual               750               1            5/60
                                         individuals screened.
Community Survey......................  Eligible high-risk                   600               1           25/60
                                         heterosexual
                                         individuals.
----------------------------------------------------------------------------------------------------------------


    Dated: December 14, 2011.
Daniel Holcomb,
Reports Clearance Officer, Centers for Disease Control and Prevention.
[FR Doc. 2011-32495 Filed 12-19-11; 8:45 am]
BILLING CODE 4163-18-P